- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0013662

Mednios Pharmaceuticals Private Limited
About Mednios Pharmaceuticals Private Limited
Data last updated:
Mednios Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 18 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24110BR2020PTC045523. Its GSTIN is 10AANCM3375J1ZD (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepak Kumar Jha and Phool Jha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O – Deepak Kr Jha At Jakriyapur Khemnichak, Patna, Bihar, India – 800020.
As per the financials filed for FY 2025, the company reported a revenue of ₹60.84 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net loss of ₹10,048 (net margin -0.2%) and EBITDA of -₹3,074 (EBITDA margin -0.1%). Revenue has grown at a compounded annual rate (CAGR) of 48% over three years.
Mednios Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0013662).
Company details
Recognitions & Rankings of Mednios Pharmaceuticals
Contact details
Mednios Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressC/O – Deepak Kr Jha At Jakriyapur Khemnichak, Patna, Bihar, India – 800020
- IndustryChemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds
To see the full contact details of Mednios Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mednios Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mednios Pharmaceuticals Private Limited, buy the company report.
Financials of Mednios Pharmaceuticals Private Limited
FY 2025 filings availableMednios Pharmaceuticals Private Limited reported revenue of ₹60.84 Lakh (up 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 48% over three years, including 32% growth in the latest year. EBITDA rose 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3,074 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10,048 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.1% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mednios Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mednios Pharmaceuticals Private Limited
Mednios Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Kumar Jha | Director | 18 Feb 2020 | 6 Years 8 Months | Current |
| Phool Jha | Director | 18 Feb 2020 | 6 Years 8 Months | Current |
Peer comparison
Mednios Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aidotick Pharmaceuticals Private Limited | ₹61.08 Lakh (FY 2024) | -60.0% | Ahmedabad, Gujarat, India | |||
| Meditell Pharmaceuticals Private Limited | ₹60.98 Lakh (FY 2024) | 56.0% | Aurangabad, Maharashtra, India | |||
| Million Pharmaceuticals Private Limited | ₹60.92 Lakh (FY 2017) | -2.0% | Muktsar, Punjab, India | |||
| Mednios Pharmaceuticals Private Limitedthis company | ₹60.84 Lakh (FY 2025) | -₹10,048 | -0.2% | 32.0% | Patna, Bihar, India | |
| VNH Pharmaceuticals Private Limited | ₹60.62 Lakh (FY 2021) | -38.0% | Shameerpet, Telangana, India |
To see the full peer comparison of Mednios Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mednios Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mednios Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mednios Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AANCM3375J1ZD | Bihar | Active | 18 Feb 2020 |
To see the full GST registrations and return filing status of Mednios Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mednios Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Deepak Kumar Jha was appointed as Director on 18 Feb 2020.
Frequently asked questions
Mednios Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 18 February 2020 (6+ years old) and is registered under CIN U24110BR2020PTC045523.
Mednios Pharmaceuticals has 2 current directors:
- Deepak Kumar Jha - Director
- Phool Jha - Director
The latest financial statements of Mednios Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Mednios Pharmaceuticals is 10AANCM3375J1ZD, registered in Bihar.
The CIN (Corporate Identification Number) of Mednios Pharmaceuticals is U24110BR2020PTC045523. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mednios Pharmaceuticals was incorporated on 18 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Mednios Pharmaceuticals by revenue are Aidotick Pharmaceuticals Private Limited, Meditell Pharmaceuticals Private Limited, Million Pharmaceuticals Private Limited, VNH Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Deepak Kumar Jha was appointed as Director on 18 Feb 2020. Phool Jha was appointed as Director on 18 Feb 2020.
Yes, Mednios Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0013662).
The registered office of Mednios Pharmaceuticals is at CO – Deepak Kr Jha At Jakriyapur Khemnichak, Patna, Bihar, India – 800020.
Mednios Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

